文献速递主动脉疾病

经胸超声心动图筛查腹主动脉瘤:系统综述与荟萃分析

Screening for Abdominal Aortic Aneurysm During Transthoracic Echocardiography: A Systematic Review and Meta-analysis.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2018-02-09

该系统综述与荟萃分析纳入20项观察性队列研究、共43,341例接受经胸超声心动图检查的患者,评估同期筛查腹主动脉瘤的可行性及患病率。结果显示主动脉可视化率为86%,筛查人群中腹主动脉瘤合并患病率为0.033(95%CI 0.024-0.044),男性0.046、女性0.014。作者认为该策略可能识别高危人群,但成本效果与临床获益尚需进一步研究。

要点

  • 经胸超声心动图检查时主动脉可视化率为86%,同期筛查腹主动脉瘤可行。
  • 筛查人群腹主动脉瘤合并患病率为0.033,男性0.046高于女性0.014。
  • 检出腹主动脉瘤者的临床结局报告不足,成本效果与临床获益待研究。

核心结论

  • 经胸超声心动图期间筛查腹主动脉瘤可能识别腹主动脉瘤高风险人群,针对性筛查可能有益。
  • 该场景下腹主动脉瘤筛查的成本效果与临床获益仍需进一步研究。

研究设计与样本

  • 系统综述与荟萃分析,遵循PRISMA声明标准,检索电子文献库。
  • 纳入20项观察性队列研究,共43,341例参与者(23,291名男性、20,050名女性)。
  • 采用固定效应或随机效应模型计算合并患病率估计。

主要发现

  • 筛查人群中高血压占41%(95%CI 38-43),高胆固醇血症占31%(95%CI 29-32)。
  • 糖尿病占20%(95%CI 19-22),吸烟占37%(95%CI 35-38)。
  • 主动脉可视化率为86%(95%CI 84-88)。
  • 筛查人群腹主动脉瘤合并患病率为0.033(95%CI 0.024-0.044)。
  • 男性腹主动脉瘤合并患病率为0.046(95%CI 0.032-0.065),女性为0.014(95%CI 0.008-0.022)。

关键数值与推荐

  • 检出腹主动脉瘤者的平均年龄在各研究间为66至85岁。
  • 检出动脉瘤的平均直径在各研究间为35 mm至45 mm。
  • 检出腹主动脉瘤参与者的临床结局报告不足。

临床怎么用

  • 对接受经胸超声心动图检查的患者,可考虑同期评估腹主动脉以筛查腹主动脉瘤。
  • 男性筛查人群腹主动脉瘤患病率高于女性,针对性筛查可能获益。
  • 临床决策需权衡该筛查策略尚未明确的成本效果与临床获益。

局限性

  • 纳入研究均为观察性队列研究。
  • 检出腹主动脉瘤参与者的临床结局报告不足。
  • 成本效果与临床获益尚未在该场景下得到研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Screening for abdominal aortic aneurysm (AAA) during transthoracic echocardiography (TTE) may be an effective targeted screening strategy. OBJECTIVE: The aim was to assess the feasibility of AAA screening during TTE and to estimate the prevalence of AAA in patients undergoing TTE. METHODS: Electronic bibliographic sources were interrogated using a combination of free text and controlled vocabulary searches to identify studies reporting on AAA screening during TTE. The review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement standards. Fixed effect or random effects models were used to calculate pooled prevalence estimates. RESULTS: Twenty observational cohort studies were identified reporting a total of 43,341 participants (23,291 men and 20,050 women). Hypertension was reported in 41% (95% CI 38-43), hypercholesterolemia in 31% (95% CI 29-32), diabetes mellitus in 20% (95% CI 19-22), and tobacco use in 37% (95% CI 35-38). The aorta was visualised in 86% (95% CI 84-88) of the screened population. The pooled prevalence of AAA in the entire screened population was 0.033 (95% CI 0.024-0.044). The pooled prevalence of AAA in men was 0.046 (95% CI 0.032-0.065) and in women it was 0.014 (95% CI 0.008-0.022). The mean age of participants in whom an AAA was detected ranged across the studies from 66 to 85 years. The mean diameter of the aneurysm identified ranged across the studies from 35 mm to 45 mm. Clinical outcomes in participants with a detected AAA were poorly reported. CONCLUSIONS: Screening for AAA during TTE may identify a population group with a high risk of AAA in whom targeted screening may be beneficial. Further research is required to investigate the cost-effectiveness and clinical benefits of AAA screening in this setting.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Argyriou C, Georgiadis GS, Kontopodis N, et al. Screening for Abdominal Aortic Aneurysm During Transthoracic Echocardiography: A Systematic Review and Meta-analysis. Eur J Vasc Endovasc Surg. 2018. PMID: 29433798. doi:10.1016/j.ejvs.2018.01.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。